Lista de obras - Fernando Aranda - Dominio Público Uruguay

Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity

artículo científico publicado en 2019

Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

article

Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model

artículo científico publicado en 2016

CD5 as a Target for Immune-Based Therapies

artículo científico

CD6 modulates thymocyte selection and peripheral T cell homeostasis

scientific article published on 04 July 2016

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

artículo científico publicado en 2016

Classification of current anticancer immunotherapies

artículo científico publicado en 2014

Consensus guidelines for the detection of immunogenic cell death

artículo científico publicado en 2014

Erratum for Martínez-Florensa et al., "Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis".

artículo científico publicado en 2017

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

artículo científico publicado en 2017

Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.

artículo científico publicado en 2017

Gut microbiota metabolites for sweetening type I diabetes.

artículo científico publicado en 2017

Harnessing high density lipoproteins to block transforming growth factor beta and to inhibit the growth of liver tumor metastases

artículo científico publicado en 2014

Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer

artículo científico publicado en 2014

Immunomodulatory effects of soluble CD5 on experimental tumor models.

artículo científico publicado en 2017

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 30 July 2020

Impact of myeloid cells on the efficacy of anticancer chemotherapy

artículo científico publicado en 2014

Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGF 1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

scientific article published on 15 December 2010

Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival

artículo científico publicado en 2016

Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function.

artículo científico publicado en 2016

Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I.

artículo científico publicado en 2015

Myeloid-derived cells are key targets of tumor immunotherapy

artículo científico publicado en 2014

Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.

artículo científico publicado en 2009

Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.

artículo científico publicado en 2016

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 17 September 2020

Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance

artículo científico publicado en 2017

Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents

artículo científico publicado en 2020

Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis

artículo científico publicado en 2022

The impact of PKR activation: from neurodegeneration to cancer.

artículo científico

Transforming growth factor beta (TGF-β) activity in immuno-oncology studies

scientific article published on 12 July 2019

Transgenic Tumor Models for Evaluating CAR T-Cell Immunotherapies

scientific article published on 01 September 2019

Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α

artículo científico publicado en 2019

Trial Watch-Immunostimulation with cytokines in cancer therapy

artículo científico publicado en 2015

Trial Watch-Oncolytic viruses and cancer therapy

artículo científico publicado en 2015

Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy

artículo científico publicado en 2016

Trial Watch: Adoptive cell transfer for anticancer immunotherapy

artículo científico publicado en 2014

Trial Watch: Adoptive cell transfer for oncological indications

artículo científico publicado en 2015

Trial Watch: Chemotherapy with immunogenic cell death inducers.

artículo científico publicado en 2014

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

artículo científico publicado en 2015

Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications

artículo científico publicado en 2015

Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

scholarly article by Elena García-Martínez et al published 2018 in OncoImmunology

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy

artículo científico publicado en 2014

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

artículo científico publicado en 2016

Trial Watch: Peptide vaccines in cancer therapy

artículo científico publicado en 2013

Trial Watch: Toll-like receptor agonists in oncological indications

artículo científico publicado en 2014

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

artículo científico publicado en 2014

Trial watch: Dendritic cell-based anticancer therapy

artículo científico publicado en 2014

Trial watch: IDO inhibitors in cancer therapy

artículo científico publicado en 2014

Trial watch: Immune checkpoint blockers for cancer therapy

artículo científico publicado en 2017

Trial watch: Immunostimulatory cytokines in cancer therapy

artículo científico publicado en 2014

Trial watch: Naked and vectored DNA-based anticancer vaccines

artículo científico publicado en 2015

Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination.

artículo científico publicado en 2015

Vitamin B6 improves the immunogenicity of cisplatin-induced cell death

artículo científico publicado en 2014

Lista de obras de Fernando Aranda

Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity

Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model

CD5 as a Target for Immune-Based Therapies

CD6 modulates thymocyte selection and peripheral T cell homeostasis

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

Classification of current anticancer immunotherapies

Consensus guidelines for the detection of immunogenic cell death

Erratum for Martínez-Florensa et al., "Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis".

Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.

Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.

Gut microbiota metabolites for sweetening type I diabetes.

Harnessing high density lipoproteins to block transforming growth factor beta and to inhibit the growth of liver tumor metastases

Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer

Immunomodulatory effects of soluble CD5 on experimental tumor models.

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Impact of myeloid cells on the efficacy of anticancer chemotherapy

Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGF 1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival

Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function.

Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I.

Myeloid-derived cells are key targets of tumor immunotherapy

Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.

Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance

Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents

Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis

The impact of PKR activation: from neurodegeneration to cancer.

Transforming growth factor beta (TGF-β) activity in immuno-oncology studies

Transgenic Tumor Models for Evaluating CAR T-Cell Immunotherapies

Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α

Trial Watch-Immunostimulation with cytokines in cancer therapy

Trial Watch-Oncolytic viruses and cancer therapy

Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy

Trial Watch: Adoptive cell transfer for anticancer immunotherapy

Trial Watch: Adoptive cell transfer for oncological indications

Trial Watch: Chemotherapy with immunogenic cell death inducers.

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications

Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

Trial Watch: Peptide vaccines in cancer therapy

Trial Watch: Toll-like receptor agonists in oncological indications

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

Trial watch: Dendritic cell-based anticancer therapy

Trial watch: IDO inhibitors in cancer therapy

Trial watch: Immune checkpoint blockers for cancer therapy

Trial watch: Immunostimulatory cytokines in cancer therapy

Trial watch: Naked and vectored DNA-based anticancer vaccines

Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination.

Vitamin B6 improves the immunogenicity of cisplatin-induced cell death